Adipose-Derived Stem Cells as Carrier of Pro-Apoptotic Oncolytic Myxoma Virus: To Cross the Blood–Brain Barrier and Treat Murine Glioma
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms252011225 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Joanna Jazowiecka-Rakus und 4 weiteren Autor:innen. Beteiligte Einrichtung: Center for Translational Research and Molecular Biology of Cancer, Maria Skłodowska-Curie National Research Institute of Oncology, Gliwice Branch, Wy…. Hauptthemen laut MEDLINE: Blood-Brain Barrier, Myxoma virus, Glioma, Oncolytic Virotherapy. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, Maria Skłodowska-Curie National Institute of Oncology - State Research Institute, Poland, National Science Center.
Abstract (Originalsprache)
Treatment of glioblastoma is ineffective. Myx-M011L-KO/EGFP, a myxoma virus actively inducing apoptosis in BTICs linked to recurrence, offers innovative treatment. We loaded this construct into adipose-derived stem cells (ADSCs) to mitigate antiviral host responses and enable systemic delivery. The apoptotic and cytotoxic effects of the construct were studied using murine and human glioblastoma cell lines. Before implementing systemic delivery, we delivered the construct locally using ADSC to verify elimination of orthotopic murine glioma lesions. vMyx-M011L-KO/EGFP was cytotoxic to a murine cell line, preventing effective virus multiplication. In three human glioma cell lines, viral replication did occur, coupled with cell killing. The knock-out construct induced apoptotic cell death in these cultures. ADSCs infected ex vivo were shown to be sufficiently migratory to assure transfer of the therapeutic cargo to murine glioma lesions. Virus-loaded ADSCs applied to the artificial blood–brain barrier (BBB) yielded viral infection of glioma cells grown distally in the wells. Two rounds of local administration of this therapeutic platform starting 6 days post tumor implantation slowed down growth of orthotopic lesions and improved survival (total recovery < 20%). ADSCs infected ex vivo with vMyx-M011L-KO/EGFP show promise as a therapeutic tool in systemic elimination of glioma lesions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Center for Translational Research and Molecular Biology of Cancer, Maria Skłodowska-Curie National Research Institute of Oncology, Gliwice Branch, Wybrzeże AK 15, 44-102 Gliwice, Poland.
- School of Life Sciences, Arizona State University, Tempe, AZ 85281, USA.
- Center for Personalized Diagnostics, Biodesign Institute, Arizona State University, Tempe, AZ 85281, USA.
ORCID-Profile: Joanna Jazowiecka-Rakus, Masmudur M Rahman, Grant McFadden, Aleksander Sochanik
Förderung
- NIAID NIH HHS
- Maria Skłodowska-Curie National Institute of Oncology - State Research Institute, Poland
- National Science Center
- National Science Centre
- Maria Skłodowska-Curie National Institute of Oncology—State Research Institute
Zitieren
APA
Jazowiecka-Rakus, J., Pogoda-Mieszczak, K., Rahman, M. M., McFadden, G., & Sochanik, A. (2024). Adipose-Derived Stem Cells as Carrier of Pro-Apoptotic Oncolytic Myxoma Virus: To Cross the Blood–Brain Barrier and Treat Murine Glioma. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms252011225
Vancouver
Jazowiecka-Rakus J, Pogoda-Mieszczak K, Rahman MM, McFadden G, Sochanik A. Adipose-Derived Stem Cells as Carrier of Pro-Apoptotic Oncolytic Myxoma Virus: To Cross the Blood–Brain Barrier and Treat Murine Glioma. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms252011225
BibTeX
@article{JazowieckaRakus2024,
author = {Jazowiecka-Rakus, Joanna and Pogoda-Mieszczak, Kinga and Rahman, Masmudur M and McFadden, Grant and Sochanik, Aleksander},
title = {Adipose-Derived Stem Cells as Carrier of Pro-Apoptotic Oncolytic Myxoma Virus: To Cross the Blood–Brain Barrier and Treat Murine Glioma},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms252011225}
}
EUVIMED